Cargando…
Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue
BACKGROUND: There is resurgence within drug and biomarker development communities for the use of primary tumorgraft models as improved predictors of patient tumor response to novel therapeutic strategies. Despite perceived advantages over cell line derived xenograft models, there is limited data com...
Autores principales: | Monsma, David J, Monks, Noel R, Cherba, David M, Dylewski, Dawna, Eugster, Emily, Jahn, Hailey, Srikanth, Sujata, Scott, Stephanie B, Richardson, Patrick J, Everts, Robin E, Ishkin, Aleksandr, Nikolsky, Yuri, Resau, James H, Sigler, Robert, Nickoloff, Brian J, Webb, Craig P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439334/ https://www.ncbi.nlm.nih.gov/pubmed/22709571 http://dx.doi.org/10.1186/1479-5876-10-125 |
Ejemplares similares
-
Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling
por: Foley, Jessica M, et al.
Publicado: (2015) -
Development and Histopathological Characterization of Tumorgraft Models of Pancreatic Ductal Adenocarcinoma
por: Garcia, Patrick L., et al.
Publicado: (2013) -
A renal cell carcinoma tumorgraft platform to advance precision medicine
por: Elias, Roy, et al.
Publicado: (2021) -
A new tumorgraft panel to accelerate precision medicine in prostate cancer
por: Béraud, Claire, et al.
Publicado: (2023) -
Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts
por: ANDERSEN, NICHOLAS J., et al.
Publicado: (2015)